DNA2 and ovarian carcinoma: Mutations in DNA2 found in ovarian cancers impair DNA2 activity (Figure 2) and depletion of DNA2 in estrogen-responding cells (MCF7) ceases proliferation, unless the cells are supplemented with estrogen (Figures 4E and Supplementary Figure S3E).